Articles From: TSX Delisting Review - Niocan Inc. (Symbol: NIO) to BJ's Restaurants, Inc. Reports Fiscal Third Quarter Results


TSX Delisting Review - Niocan Inc. (Symbol: NIO) Canada NewsWire TORONTO , Oct.
Sign-up for TSX Delisting Review - Niocan Inc. (Symbol: NIO) investment picks
RIDGEFIELD, Conn., Oct.
Sign-up for The Chefs' Warehouse Acquires Maryland Based Euro Gourmet Inc. investment picks
ANN ARBOR, Mich.
Sign-up for Con-way Freight Announces Fall 2014 General Rate Increase investment picks
-Theran to Lead Expansion of Retail Markets for 3DS' Latest Consumer Products -At Bose, Theran Oversaw Consumer Market Valued at $350M Annually ROCK HILL, S.C., Oct.
Sign-up for 3D Systems Taps Peter Theran to Lead Its Consumer Products Business investment picks
Dropless cataract surgery created a "buzz" and was a "hot topic" at this year's AAO meeting SAN DIEGO , Oct.
Sign-up for Imprimis Pharmaceuticals Reports on Positive Clinical Findings Presented at the American Academy of Ophthalmology (AAO) Annual Meeting investment picks
Qlik® (NASDAQ: QLIK), a leader in data discovery, today announced that AmerisourceBergen, one of the largest global pharmaceutical sourcing and distribution services companies, has signed an enterprise deal to significantly extend its use of Qlik products, deploying both QlikView® and Qlik® Sense widely across the enterprise.
Sign-up for AmerisourceBergen Selects Qlik as Global Standard for Analytics investment picks
ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted its final opinion on Iclusig ® (ponatinib) following the recommendations made by the Pharmacovigilance Risk Assessment Committee (PRAC) earlier this month.
Sign-up for ARIAD Announces Adoption of Final Opinion for Iclusig by Committee for Medicinal Products for Human Use in Europe investment picks
Moody’s Corporation (NYSE:MCO) today announced results for the third quarter 2014.
Sign-up for Moody's Corporation Reports Results for Third Quarter 2014 investment picks
NGL Energy Partners LP (NYSE: NGL) announced today that the Board of Directors of its general partner declared a quarterly distribution of $0.60875 per unit ($2.435 on an annualized basis) for the quarter ended September 30, 2014.
Sign-up for NGL Energy Partners Announces Increased Quarterly Cash Distribution investment picks
ImmunoGen, Inc .
Sign-up for ImmunoGen, Inc. Reports First Quarter Fiscal Year 2015 Financial Results investment picks
SHENZHEN, China, Oct.
Sign-up for iDreamSky Launches Card Battle Game "Sky Fall" in China investment picks
Conference Call Scheduled for Monday, November 10 LEHI, Utah , Oct.
Sign-up for Vivint Solar to Report Third Quarter 2014 Financial Results investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0974650001&sourceType=1 http://media3.marketwire.com/logos/20140319-delphi.jpg CALGARY, ALBERTA --
Sign-up for Delphi Energy Provides Operations Update investment picks
SAN JOSE, Calif., Oct.
Sign-up for Heritage Commerce Corp Declares Quarterly Cash Dividend of $0.05 Per Share investment picks
http://media.marketwire.com/attachments/201203/41309_medivation_logo.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1153765&ProfileId=051205&sourceType=1 SAN FRANCISCO, CA and YAVNE, ISRAEL --
Sign-up for Medivation Inc. Licenses Clinical Stage Anti-PD-1 Immune Modulatory Monoclonal Antibody From CureTech Ltd. for Potential Applications in Oncology investment picks
CHARLOTTE , Oct.
Sign-up for Tree.com, Inc. to Report Third Quarter 2014 Earnings on November 6, 2014 investment picks
MILLERSBURG, Pa., Oct.
Sign-up for Mid Penn Bancorp, Inc. Reports Third Quarter Earnings and Declares Dividend investment picks
Clovis Oncology, Inc. (NASDAQ: CLVS) announced today that its global Phase 2 study of lucitanib in patients with FGFR1-amplified squamous non-small cell lung cancer (NSCLC) has commenced and the first patient has been dosed at a U.S. study site.
Sign-up for Clovis Oncology Announces First Patient Enrolled in Lucitanib Phase 2 Study in Squamous Non-small Cell Lung Cancer investment picks
Pfizer shares (PFE) rose 1.4% in after-hours trade Thusday after the blue-chip drug maker said it has authorized a new $11 billion share buyback program, to be "utilized over time." That is in addition to the $1.3 billion left in its previous repurchase program.
Sign-up for Pfizer shares rise after new $11 billion share buyback program investment picks
ATLANTA , Oct.
Sign-up for Alimera Sciences to Release Third Quarter 2014 Results investment picks
REDWOOD CITY, Calif., Oct.
Sign-up for Informatica Names Michael Berry as Executive Vice President and Chief Financial Officer investment picks
Westwood Holdings Group, Inc. (NYSE: WHG) today reported third quarter 2014 revenues of $28.1 million, 22% higher than revenues of $23.0 million in the third quarter of 2013.
Sign-up for Westwood Holdings Group, Inc. Reports Third Quarter 2014 Results investment picks
BELTSVILLE, Md., Oct.
Sign-up for TerraForm Power, Inc. to Host Third Quarter 2014 Results Conference Call investment picks
Dolby Laboratories, Inc. (NYSE:DLB) today announced the Company’s financial results for the fourth quarter and fiscal year that ended September 26, 2014.
Sign-up for Dolby Laboratories Reports Fourth Quarter and Fiscal Year 2014 Financial Results investment picks
HUNTINGTON BEACH, Calif., Oct.
Sign-up for BJ's Restaurants, Inc. Reports Fiscal Third Quarter Results investment picks
Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.

Mobile

Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: TSX Delisting Review - Niocan Inc. (Symbol: NIO) to BJ's Restaurants, Inc. Reports Fiscal Third Quarter Results
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent